NovavaxNVAX 
$12.56-2.86%24h
-2.86%24h
Global rank6195
Market cap$1.49B
Change 7d12.54%
YTD Performance160.58%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Market capitalization of Novavax (NVAX)
As of November 2024, Novavax has a market cap of $1.49B. This makes Novavax the world's 6195th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Novavax from 1995 to 2024
-
Value:-
Market cap history of Novavax from 1995 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $510.20M | -10.52% |
| 2023 | $570.19M | -53.31% |
| 2022 | $1.22B | -92.81% |
| 2021 | $17.00B | 28.30% |
| 2020 | $13.25B | 2701.76% |
| 2019 | $472.78M | -89.18% |
| 2018 | $4.37B | 48.39% |
| 2017 | $2.95B | -1.59% |
| 2016 | $2.99B | -84.98% |
| 2015 | $19.93B | 41.48% |
| 2014 | $14.09B | 15.82% |
| 2013 | $12.16B | 170.90% |
| 2012 | $4.49B | 50.00% |
| 2011 | $2.99B | -48.15% |
| 2010 | $5.77B | -8.65% |
| 2009 | $6.32B | 40.74% |
| 2008 | $4.49B | -43.24% |
| 2007 | $7.91B | -18.78% |
| 2006 | $9.74B | 6.49% |
| 2005 | $9.15B | 18.10% |
| 2004 | $7.75B | -45.67% |
| 2003 | $14.25B | 130.77% |
| 2002 | $6.18B | -81.56% |
| 2001 | $33.50B | 65.88% |
| 2000 | $20.19B | 51.11% |
| 1999 | $13.36B | 190.32% |
| 1998 | $4.60B | -61.25% |
| 1997 | $11.88B | 45.45% |
| 1996 | $8.17B | -8.33% |
| 1995 | $8.91B | - |
NVAX Market Cap Today is $1.49B -2.86% - 5 Nov 2024
View largest stocks by market cap 
